This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Contarino, A. Articles by Gold, L. H. Search for Related Content PubMed PubMed Citation Articles by Contarino, A. Articles by Gold, L. H.

Dissociation of Locomotor Activation and Suppression of Food Intake Induced by CRF in CRFR1-Deficient Mice

The Scripps Research Institute, Department of Neuropharmacology (A.C., F.D., G.F.K., L.H.G.), and Clayton Foundation Laboratories for Peptide Biology, The Salk Institute (G.W.S., K.F.L., W.V.), La Jolla, California 92037

Address all correspondence and requests for reprints to: Lisa H. Gold, The Scripps Research Institute, Department of Neuropharmacology, 10550 North Torrey Pines Road, La Jolla, California 92037.

ABSTRACT

Corticotropin-releasing factor (CRF) systems are involved in locomotor and feeding behaviors. Two distinct CRF receptor subtypes, CRFR1 and CRFR2, are thought to mediate CRF actions in the central nervous system. However, the role for each receptor in locomotor activity and feeding remains to be determined. Using CRFR1 null mutant mice, the present study examined the functional significance of this receptor in ambulation and feeding. CRF treatment of wild-type mice resulted in increased levels of locomotion whereas no change was observed in CRFR1-deficient mice as compared to vehicle-treated mutant mice. In contrast, CRF decreased food-water intake in both wild type and CRFR1-deficient mice equally. These results support an important role for CRFR1 in mediating CRF-induced locomotor activation, whereas other receptor subtypes, likely CRFR2, may mediate the appetite-suppressing effects of CRF-like peptides.

This article has been cited by other articles:

				M. J. Wanat, F. W. Hopf, G. D. Stuber, P. E. M. Phillips, and A. Bonci Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih J. Physiol., April 15, 2008; 586(8): 2157 - 2170. [Abstract] [Full Text] [PDF]

				L. Mattioli and M. Perfumi Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats J Psychopharmacol, September 1, 2007; 21(7): 742 - 750. [Abstract] [PDF]

				K. M. Carlin, W. W. Vale, and T. L. Bale Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis PNAS, February 28, 2006; 103(9): 3462 - 3467. [Abstract] [Full Text] [PDF]

				A. Contarino and F. Papaleo The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal PNAS, December 20, 2005; 102(51): 18649 - 18654. [Abstract] [Full Text] [PDF]

				T. L. Bale, K. R. Anderson, A. J. Roberts, K.-F. Lee, T. R. Nagy, and W. W. Vale Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and Cold Endocrinology, June 1, 2003; 144(6): 2580 - 2587. [Abstract] [Full Text] [PDF]

				K. Inoue, G. R. Valdez, T. M. Reyes, L. E. Reinhardt, A. Tabarin, J. Rivier, W. W. Vale, P. E. Sawchenko, G. F. Koob, and E. P. Zorrilla Human Urocortin II, a Selective Agonist for the Type 2 Corticotropin-Releasing Factor Receptor, Decreases Feeding and Drinking in the Rat J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 385 - 393. [Abstract] [Full Text]

				M. A. Pelleymounter, M. Joppa, N. Ling, and A. C. Foster Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 145 - 152. [Abstract] [Full Text] [PDF]

				D. J. Marsh, D. T. Weingarth, D. E. Novi, H. Y. Chen, M. E. Trumbauer, A. S. Chen, X.-M. Guan, M. M. Jiang, Y. Feng, R. E. Camacho, et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism PNAS, February 20, 2002; (2002) 52706899. [Abstract] [Full Text] [PDF]

				K. Eckart, O. Jahn, J. Radulovic, H. Tezval, L. van Werven, and J. Spiess A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists PNAS, September 25, 2001; 98(20): 11142 - 11147. [Abstract] [Full Text] [PDF]

				T. M. Reyes, K. Lewis, M. H. Perrin, K. S. Kunitake, J. Vaughan, C. A. Arias, J. B. Hogenesch, J. Gulyas, J. Rivier, W. W. Vale, et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors PNAS, February 27, 2001; 98(5): 2843 - 2848. [Abstract] [Full Text] [PDF]

				D. J. Marsh, D. T. Weingarth, D. E. Novi, H. Y. Chen, M. E. Trumbauer, A. S. Chen, X.-M. Guan, M. M. Jiang, Y. Feng, R. E. Camacho, et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism PNAS, March 5, 2002; 99(5): 3240 - 3245. [Abstract] [Full Text] [PDF]